We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Current Strategies to Modulate Regulatory T Cell Activity in Allergic Inflammation
Summary
This review summarized current strategies to modulate regulatory T cell activity in allergic inflammation, covering approaches from allergen immunotherapy to biologics that aim to restore immune tolerance in atopic diseases affecting up to 50% of people in industrialized countries.
Over the past decades, atopic diseases, including allergic rhinitis, asthma, atopic dermatitis, and food allergy, increased strongly worldwide, reaching up to 50% in industrialized countries. These diseases are characterized by a dominating type 2 immune response and reduced numbers of allergen-specific regulatory T (Treg) cells. Conventional allergen-specific immunotherapy is able to tip the balance towards immunoregulation. However, in mouse models of allergy adaptive transfer of Treg cells did not always lead to convincing beneficial results, partially because of limited stability of their regulatory phenotype activity. Besides genetic predisposition, it has become evident that environmental factors like a westernized lifestyle linked to modern sanitized living, the early use of antibiotics, and the consumption of unhealthy foods leads to epithelial barrier defects and dysbiotic microbiota, thereby preventing immune tolerance and favoring the development of allergic diseases. Epigenetic modification of Treg cells has been described as one important mechanism in this context. In this review, we summarize how environmental factors affect the number and function of Treg cells in allergic inflammation and how this knowledge can be exploited in future allergy prevention strategies as well as novel therapeutic approaches.
Sign in to start a discussion.
More Papers Like This
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
This review examines biomarkers used for diagnosing and predicting treatment responses in allergic diseases and asthma, focusing on advances in personalized medicine. Researchers discuss how molecular and cellular markers can help classify disease subtypes and guide targeted therapies. The study highlights the shift toward precision medicine approaches that tailor treatments to individual patient profiles rather than using one-size-fits-all strategies.
The interconnection between environment, immune-nutrition and allergic disease
This review explores the connections between environmental factors, immune-nutrition, and the rising global prevalence of allergic diseases. The study discusses how climate change, air pollution, biodiversity loss, and environmental contaminants including microplastics contribute to immune dysregulation, and highlights the role of the microbiome and dietary factors in modulating allergic disease risk.
All the small things: How virus‐like particles and liposomes modulate allergic immune responses
This review examines how virus-like nanoparticles and liposomes are being engineered as antigen delivery platforms for allergy treatment, discussing their ability to break immunological tolerance against endogenous cytokines and IgE. The authors critically assess the pros and cons of inducing neutralising autoantibodies and review progress toward non-anaphylactogenic particle designs in preclinical and clinical allergy studies.
Cellular and molecular mechanisms of allergic asthma
Researchers reviewed the cellular and molecular mechanisms behind allergic asthma, finding that rising exposure to environmental pollutants — including microplastics — likely contributes to the disease's increasing prevalence, as pollutants disrupt airway barrier integrity and trigger immune responses that lead to chronic airway inflammation.
Asthma and allergic diseases: Cross talk of immune system and environmental factors
This review summarizes current understanding of how environmental factors, including the microbiome and geographic location, influence immune regulation in the context of allergy and asthma. Researchers examined how different routes of exposure to environmental agents interact with both innate and adaptive immune responses. The study highlights the need for comprehensive investigation of environmentally driven immune changes to better understand disease prevention and progression.